Composition
- Active ingredients
- BENZTROPINE MESYLATE 0.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- BENZTROPINE MESYLATE 1MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · InjectableNDA012015-001 · Discontinued
- BENZTROPINE MESYLATE 0.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · TabletThis page
- BENZTROPINE MESYLATE 2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · TabletNDA009193-002 · Discontinued
- BENZTROPINE MESYLATE 1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · TabletNDA009193-003 · Discontinued
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA009193.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Cogentin
- Active substance
- benztropine mesylate
- Route
- Oral
- Dosage form
- Tablet
- Applicant
- Merck
- Status
- Discontinued
- FDA approval
- 5 Mar 1954
- Application
- NDA009193-004